Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007

AIDS

Volumn 24, Issue 14, 2010, Pages 2263-2270

  Cornell, Morna ^a,b   Grimsrud, Anna ^a   Fairall, Lara ^a,c   Fox, Matthew P ^b,d   Van Cutsem, Gilles ^a,e   Giddy, Janet ^f   Wood, Robin ^a   Prozesky, Hans ^g   Mohapi, Lerato ^b   Graber, Claire ^h   Egger, Matthias ^h,i   Boulle, Andrew ^a   Myer, Landon ^a,j  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e MÉDECINS SANS FRONTIÈRES   (Switzerland)

^f MCCORD HOSPITAL   (South Africa)

^g STELLENBOSCH UNIVERSITY   (South Africa)

^h UNIVERSITY OF BERN   (Switzerland)

ⁱ UNIVERSITY OF BRISTOL   (United Kingdom)

^j Treatment Programs   (United States)

more..

Author keywords

antiretroviral therapy (highly active); loss to follow up; mortality; programme outcomes; retention; South Africa; survival analysis

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ADULT; ARTICLE; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MORTALITY; PATIENT CARE; PRIORITY JOURNAL; RISK FACTOR; SOUTH AFRICA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT ACCEPTANCE OF HEALTH CARE; PROGRAM EVALUATION; SOUTH AFRICA; YOUNG ADULT;

EID: 77956229669     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32833d45c5     Document Type: Article

References (30)

1. World Health Organization, UNAIDS, UNICEF. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: progress report. Geneva: WHO; 2007.
2. UNAIDS. Progress Report on Declaration of Commitment on HIV and AIDS: Republic of South Africa: Reporting period: January 2006-December 2007. See: http://data.unaids.org/pub/Report/2008/south-africa-2008-progress-report-en.pdf
3. Cornell M, Technau K, Fairall LR, Wood R, Moultrie H, Van Cutsem G, et al. Monitoring the South African National Anti-retroviral Treatment Programme, 2003-2007: the IeDEA Southern Africa Collaboration. S Afr Med J 2009; 99:653-660.
4. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 2008; 22:1897-1908.
5. Zachariah R, Harries K, Moses M, Manzi M, Line A,Mwagomba B, Harries AD. Very early mortality in patients starting anti-retroviral treatment at primary health centres in rural Malawi. Trop Med Int Health 2009; 14:713-721.
6. Harries AD, Zachariah R, Jahn A, Schouten EJ, Kamoto K. Scaling up antiretroviral therapy in Malawi-implications for managing other chronic diseases in resource-limited countries. J Acquir Immune Defic Syndr 2009; 52 (Suppl 1):S14-S16.
7. Massaquoi M, Zachariah R, Manzi M, Pasulani O, Misindi D, Mwagomba B, et al. Patient retention and attrition on antire-troviral treatment at district level in rural Malawi. Trans R Soc Trop Med Hyg 2009; 103:594-600.
8. Boulle A, Ford N. Scaling up antiretroviral therapy in developing countries: what are the benefits and challenges? Sex Transm Infect 2007; 83:503-505.
9. Harries AD, Schouten EJ, Libamba E. Scaling up antiretroviral treatment in resource-poor settings. Lancet 2006; 367:1870-1872.
10. Losina E, Toure H, Uhler LM, Anglaret X, Paltiel AD, Balestre E, et al. Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Cote d'Ivoire appraisal. PLoS Med 2009; 6:e1000173.
11. Myer L, el-Sadr W. Expanding access to antiretroviral therapy through the public sector: the challenge of retaining patients in long-term primary care. S Afr Med J 2004; 94:273-274.
12. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-saharan Africa: a systematic review. PLoS Med 2007; 4:e298.
13. Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, Miotti P, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 2006; 367:817-824.
14. Boulle A, Bock P, Osler M, Cohen K, Channing L, Hilderbrand K, et al. Antiretroviral therapy and early mortality in South Africa. Bull World Health Organ 2008; 86:678-687.
15. Brinkhof MW, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One 2009; 4:e5790.
16. Boulle A, Van Cutsem G, Hilderbrand K, Cragg C, Abrahams M, Mathee S, et al. Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. AIDS 2010:24.
17. Fox MP, Brennan A, Maskew M, PacPhail P, Sanne I. Using vital registration data to update mortality among patients lost to follow-up from ART programmes: evidence from the Themba Lethu Clinic, South Africa. Trop Med Int Health, 15:405-413.
18. Mathers C, Boerma T. Mortality measurement matters: improving data collection and estimation methods for child and adult mortality. PLoS Med 2010; 7:e1000265.
19. Murray CJL, Rajaratnam JK, Marcus J, Laakso T, Lopez AD. What Can we conclude from death registration? Improved methods for evaluating completeness. PLoS Med 2010; 7:e1000262.
20. Obermeyer Z, Rajaratnam JK, Park CH, Gakidou E, Hogan MC, Lopez AD, Murray CJL. Measuring adult mortality using sibling survival: a new analytical method and new results for 44 countries, 1974-2006. PLoS Med 2010; 7:e1000260.
21. Coovadia H, Jewkes R, Barron P, Sanders D, McIntyre D. The health and health system of South Africa: historical roots of current public health challenges. Lancet 2009; (Special issue): 11-28.
22. Adam MA, Johnson L. Estimation of adult antiretroviral treatment coverage in South Africa. S Afr Med J 2009; 99:661-667.
23. Department of Health. The South African antiretroviral treatment guidelines 2010. http://www.sanac.org.za/documents/2010%20ART%20Guideline-Short. pdf.
24. Forster M, Bailey C, Brinkhof MW, Graber C, Boulle A, Spohr M, et al. Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings. Bull World Health Organ 2008; 86:939-947.
25. Coetzee D, Boulle A, Hildebrand K, Asselman V, Van Cutsem G, Goemaere E. Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa. AIDS 2004; 18 (Suppl 3):S27-31.
26. Nachega JB, Knowlton AR, Deluca A, Schoeman JH, Watkinson L, Efron A, et al. Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults. A qualitative study. J Acquir Immune Defic Syndr 2006; 43 (Suppl 1):S127-S133.
27. MaskewM, MacPhailP, MenezesC, Rubel D.Lost tofollow up: contributing factors and challenges in South African patients on antiretroviral therapy. S Afr Med J 2007; 97:853-857.
28. Zachariah R, Teck R, Buhendwa L, Fitzerland M, Labana S, Chinji C, et al. Community support is associated with better antiretroviral treatment outcomes in a resource-limited rural district in Malawi. Trans R Soc Trop Med Hyg 2007; 101:79-84.
29. Yu JK, Chen SC, Wang KY, Chang CS, Makombe SD, Schouten EJ, Harries AD. True outcomes for patients on antiretroviral therapy who are 'lost to follow-up' in Malawi. Bull World Health Organ 2007; 85:550-554.
30. Barron P, Roma-Reardon J, editors. South African health review 2008. Durban: Health Systems Trust; 2008.